Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deblina Raychaudhuri

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Nature Reviews. Immunology|June 13, 2022
Myeloid cell-targeted therapies for solid tumoursSangeeta Goswami, Swetha Anandhan, Deblina Raychaudhuri, et al.
Cytokine|August 31, 2019
Role of Ca<sup>2+</sup> in toll-like receptor 9 activation in human plasmacytoid dendritic cellsDeblina Raychaudhuri, Pritam Duttagupta, Chinky Shiu Chen Liu, et al.
Molecular and Cellular Endocrinology|May 23, 2025
Androgen receptor plays critical role in regulating cervical cancer cell migrationSarpita Bose, Subhrangshu Das, Sebabrata Maity, et al.
Biorxiv : the Preprint Server for Biology|June 10, 2024
Histone Lactylation Drives CD8 T Cell Metabolism and FunctionDeblina Raychaudhuri, Pratishtha Singh, Mercedes Hennessey, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 14, 2018
Cutting Edge: Piezo1 Mechanosensors Optimize Human T Cell ActivationChinky Shiu Chen Liu, Deblina Raychaudhuri, Barnali Paul, et al.
Journal of Medicinal Chemistry|April 18, 2020
A Chemical Switch for Transforming a Purine Agonist for Toll-like Receptor 7 to a Clinically Relevant AntagonistAyan Mukherjee, Deblina Raychaudhuri, Bishnu Prasad Sinha, et al.
Nature Immunology|October 7, 2024
Histone lactylation drives CD8<sup>+</sup> T cell metabolism and functionDeblina Raychaudhuri, Pratishtha Singh, Bidisha Chakraborty, et al.
European Journal of Medicinal Chemistry|October 8, 2018
Activity-guided development of potent and selective toll-like receptor 9 antagonistsBarnali Paul, Oindrila Rahaman, Swarnali Roy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 2024
Cutting Edge: ATP13A2 Is an Endolysosomal Regulator of TLR9/7 Activation in Human Plasmacytoid Dendritic CellsPurbita Bandopadhyay, Jafar Sarif, Ranit D'Rozario, et al.
Journal of Medicinal Chemistry|June 18, 2021
Systematic Optimization of Potent and Orally Bioavailable Purine Scaffold as a Dual Inhibitor of Toll-Like Receptors 7 and 9Biswajit Kundu, Deblina Raychaudhuri, Ayan Mukherjee, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Nature Reviews. Immunology|June 13, 2022
Myeloid cell-targeted therapies for solid tumoursSangeeta Goswami, Swetha Anandhan, Deblina Raychaudhuri, et al.
Cytokine|August 31, 2019
Role of Ca<sup>2+</sup> in toll-like receptor 9 activation in human plasmacytoid dendritic cellsDeblina Raychaudhuri, Pritam Duttagupta, Chinky Shiu Chen Liu, et al.
Molecular and Cellular Endocrinology|May 23, 2025
Androgen receptor plays critical role in regulating cervical cancer cell migrationSarpita Bose, Subhrangshu Das, Sebabrata Maity, et al.
Biorxiv : the Preprint Server for Biology|June 10, 2024
Histone Lactylation Drives CD8 T Cell Metabolism and FunctionDeblina Raychaudhuri, Pratishtha Singh, Mercedes Hennessey, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 14, 2018
Cutting Edge: Piezo1 Mechanosensors Optimize Human T Cell ActivationChinky Shiu Chen Liu, Deblina Raychaudhuri, Barnali Paul, et al.
Journal of Medicinal Chemistry|April 18, 2020
A Chemical Switch for Transforming a Purine Agonist for Toll-like Receptor 7 to a Clinically Relevant AntagonistAyan Mukherjee, Deblina Raychaudhuri, Bishnu Prasad Sinha, et al.
Nature Immunology|October 7, 2024
Histone lactylation drives CD8<sup>+</sup> T cell metabolism and functionDeblina Raychaudhuri, Pratishtha Singh, Bidisha Chakraborty, et al.
European Journal of Medicinal Chemistry|October 8, 2018
Activity-guided development of potent and selective toll-like receptor 9 antagonistsBarnali Paul, Oindrila Rahaman, Swarnali Roy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 2024
Cutting Edge: ATP13A2 Is an Endolysosomal Regulator of TLR9/7 Activation in Human Plasmacytoid Dendritic CellsPurbita Bandopadhyay, Jafar Sarif, Ranit D'Rozario, et al.
Journal of Medicinal Chemistry|June 18, 2021
Systematic Optimization of Potent and Orally Bioavailable Purine Scaffold as a Dual Inhibitor of Toll-Like Receptors 7 and 9Biswajit Kundu, Deblina Raychaudhuri, Ayan Mukherjee, et al.
Pageof 3